These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 188019)

  • 1. Excision in vitro of the DNA bound carcinogen, 4-nitroquinoline 1-oxide.
    Yoshida S; Tada M; Tada M
    Nucleic Acids Res; 1976 Nov; 3(11):3227-33. PubMed ID: 188019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of enzymic incision of thymine dimers by covalently bound guanine adducts of 4-nitroquinoline-1-oxide in DNA.
    Duker NJ; Merkel GW
    Cancer Res; 1986 May; 46(5):2374-6. PubMed ID: 3084066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro DNA reaction with an ultimate carcinogen model of 4-nitroquinoline-1-oxide: the 4-acetoxyaminoquinoline-1-oxide. Enzymatic degradation of the modified DNA.
    Galiègue-Zouitina S; Bailleul B; Loucheux-Lefebvre MH
    Carcinogenesis; 1983; 4(3):249-54. PubMed ID: 6299600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Main binding sites of the carcinogen, 4-nitroquinoline 1-oxide in nucleic acids.
    Tada M; Tada M
    Biochim Biophys Acta; 1976 Dec; 454(3):558-66. PubMed ID: 826278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of 8-hydroxyguanine residues in cellular DNA exposed to the carcinogen 4-nitroquinoline 1-oxide.
    Kohda K; Tada M; Kasai H; Nishimura S; Kawazoe Y
    Biochem Biophys Res Commun; 1986 Sep; 139(2):626-32. PubMed ID: 3094520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanyl-C8-arylamination of DNA by the ultimate carcinogen of 4-nitroquinoline-1-oxide: a spectrophotometric titration.
    Galiègue-Zouitina S; Bailleul B; Loucheux-Lefebvre MH
    Anal Biochem; 1984 May; 138(2):454-7. PubMed ID: 6430116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 4-nitroquinoline 1-oxide and related compounds.
    Tada M
    Carcinog Compr Surv; 1981; 6():25-45. PubMed ID: 6786744
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced bioreduction of 4-nitroquinoline 1-oxide by cultured ataxia telangiectasia cells.
    Mirzayans R; Sabour M; Paterson MC
    Carcinogenesis; 1988 Sep; 9(9):1711-5. PubMed ID: 3136948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of 4-nitroquinoline 1-oxide to 4-hydroxyaminoquinoline 1-oxide in lysates of cytomegalovirus-infected cells.
    Speelman DJ; Lund H; Culling A; Kittredge JS; Williams BJ; Albrecht T
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2511-5. PubMed ID: 6315869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioreduction of 4-nitroquinoline 1-oxide in dysplastic nevus syndrome fibroblasts.
    Mirzayans R; Sabour M; Paterson MC
    Mutat Res; 1989 Apr; 225(4):165-9. PubMed ID: 2494449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal antibodies to DNA modified with 4-nitroquinoline 1-oxide: application for the detection of 4-nitroquinoline 1-oxide-DNA adducts in vivo.
    Morita T; Ikeda S; Minoura Y; Kojima M; Tada M
    Jpn J Cancer Res; 1988 Feb; 79(2):195-203. PubMed ID: 3130354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conjugation of 4-nitroquinoline 1-oxide, a potent carcinogen, by mammalian glutathione transferases. 4-Nitroquinoline 1-oxide conjugation by human, rat and mouse liver cytosols, extrahepatic organs of mice and purified mouse glutathione transferase isoenzymes.
    Stanley JS; Benson AM
    Biochem J; 1988 Nov; 256(1):303-6. PubMed ID: 3146973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenicity of 4-nitrosoquinoline 1-oxide and its possible role in carcinogenesis by 4-nitroquinoline 1-oxide.
    Takahashi K; Kawazoe Y; Tada M; Tada M; Ito N; Okada M
    Gan; 1978 Aug; 69(4):499-505. PubMed ID: 101415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and identification of N4-(guanosin-7-yl)-4-aminoquinoline 1-oxide, a novel nucleic acid adduct of carcinogen 4-nitroquinoline 1-oxide.
    Kohda K; Kawazoe Y; Minoura Y; Tada M
    Carcinogenesis; 1991 Aug; 12(8):1523-5. PubMed ID: 1907226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of carcinogens, 4-nitroquinoline-1-oxide and 4-hydroxyaminoquinoline-1-oxide, in the nervous system and its possible neurotoxicological significance.
    Takasu T
    Experientia; 1979 May; 35(5):668-70. PubMed ID: 109308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide in adult and fetal mice.
    Lu LJ; Baxter JR; Wang MY; Harper BL; Tasaka F; Kohda K
    Cancer Res; 1990 Oct; 50(19):6192-8. PubMed ID: 2119250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the glutathione conjugate of 4-nitroquinoline 1-oxide formed in the reaction catalyzed by murine glutathione transferases.
    Stanley JS; Lay JO; Miller DW; DeLuca DC
    Carcinogenesis; 1989 Mar; 10(3):587-91. PubMed ID: 2494002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming activity of human c-Ha-ras-1 proto-oncogene generated by the binding of 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole and 4-nitroquinoline N-oxide: direct evidence of cellular transformation by chemically modified DNA.
    Hashimoto Y; Kawachi E; Shudo K; Sekiya T; Sugimura T
    Jpn J Cancer Res; 1987 Mar; 78(3):211-5. PubMed ID: 3106276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of the carcinogen 4-nitroquinoline 1-oxide with the non-protein thiols of mammalian cells.
    Varnes ME; Biaglow JE
    Cancer Res; 1979 Aug; 39(8):2960-5. PubMed ID: 110443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of 4-nitroquinoline 1-oxide carcinogenesis.
    Bailleul B; Daubersies P; Galiègue-Zouitina S; Loucheux-Lefebvre MH
    Jpn J Cancer Res; 1989 Aug; 80(8):691-7. PubMed ID: 2511172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.